BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31074728)

  • 1. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
    Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F
    Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteopontin in systemic lupus erythematosus].
    Kitagori K; Yoshifuji H
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):118-123. PubMed ID: 28603202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.
    Kitagori K; Yoshifuji H; Oku T; Sasaki C; Miyata H; Mori KP; Nakajima T; Ohmura K; Kawabata D; Yukawa N; Imura Y; Murakami K; Nakashima R; Usui T; Fujii T; Sakai K; Yanagita M; Hirayama Y; Mimori T
    PLoS One; 2016; 11(12):e0167141. PubMed ID: 27992535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
    Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
    Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus.
    Wirestam L; Saleh M; Svensson C; Compagno M; Zachrisson H; Wetterö J; Sjöwall C
    Lupus; 2021 Jul; 30(8):1244-1253. PubMed ID: 33957796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
    Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
    Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
    Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
    Liu XR; Qi YY; Zhao YF; Cui Y; Zhao ZZ
    Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
    Hafez EA; Hassan SAE; Teama MAM; Badr FM
    Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine and serum interleukin 35 as potential biomarkers of lupus nephritis.
    Nassif MA
    Cent Eur J Immunol; 2021; 46(3):351-359. PubMed ID: 34764807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
    Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
    Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.